Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
A rare systemic disease characterized by severe myalgia and peripheral eosinophilia associated with tryptophan dietary supplementation. The symptoms do not subside after tryptophan discontinuation. Clinical presentation includes muscle tenderness and cramps, fatigue, weakness, paresthesia, peripheral edema, arthralgia, dyspnea, skin rash, dry mouth, and development of scleroderma-like skin abnormalities.
Estimated prevalence: Unknown (Unknown prevalence).
No clinical trials have been registered for myalgia-eosinophilia syndrome associated with tryptophan.
2 publications have been identified in PubMed for myalgia-eosinophilia syndrome associated with tryptophan. Research spans Review / Meta-Analysis (50%) and Case Report / Case Series (50%).
Ihssan HH (2025). [PMID: 39881778](https://pubmed.ncbi.nlm.nih.gov/39881778/). *Radiol Case Rep*. [Case Report / Case Series]
Dang Y (2025). [PMID: 41137258](https://pubmed.ncbi.nlm.nih.gov/41137258/). *Medicine (Baltimore)*. [Review / Meta-Analysis]
Data assembled from 3 of 12 sources · Last updated Sep 20, 2026, 5:39 PM UTC
European rare disease database
Genetic and Rare Diseases Info Center